Company Overview and News

 
Hong Kong’s Hang Seng breaks through 30,000 points, hits decade high

2017-11-22 thehindubusinessline
Hong Kong's benchmark Hang Seng Index broke through the 30,000 point-mark on Wednesday for the first time in 10 years, amid signs Chinese investors are stepping up buying Hong Kong blue chips such as Tencent. China stocks also rose.
Upvote Downvote

 
Hong Kong budget hotel operators show interest in moving into co-living space

2017-11-22 scmp
Hong Kong budget hotels in non-core areas are keen to join other investors to convert their underperforming properties into co-living spaces, as it provides a cheaper alternative for millennials priced out of the world’s most expensive housing market.
Upvote Downvote

1
Young and fashionable willing to pay a premium for co-living space as government backs segment

2017-11-22 scmp
Yuppies with the taste for communal living in Beijing are being spoiled for choice as an increasing number of private firms move into this latest strand of residential leasing, thanks to backing from the government.
Upvote Downvote

 
Chinese developers turn to mortgage balance-ABS for liquidity

2017-11-21 in.reuters
HONG KONG (Reuters) - Chinese developers such as China Vanke and Country Garden are increasingly turning to the securitisation market as an alternative fund-raising channel as the onshore bond market remains mostly inaccessible.
Upvote Downvote

 
Chinese developers turn to mortgage balance-ABS for liquidity

2017-11-21 reuters
HONG KONG (Reuters) - Chinese developers such as China Vanke (2202.HK) and Country Garden (2007.HK) are increasingly turning to the securitization market as an alternative fund-raising channel as the onshore bond market remains mostly inaccessible.
Upvote Downvote

 
China stocks shake off shadow bank clampdown with late rally (VIDEO)

2017-11-21 themalaymailonline
A man walks out of the Shanghai Stock Exchange building at the Pudong financial district in Shanghai November 17, 2014. — Reuters picSHANGHAI, Nov 21 — Chinese stocks rallied in late trade as markets took a closer look at the nation’s new plans to rein in shadow banks and some traders speculated that state funds would act to stem excessive losses.
Upvote Downvote

 
ICBC to offer 500 billion yuan worth of credit to spur home rental market in Guangzhou

2017-11-16 scmp
Industrial and Commercial Bank of China (ICBC), the nation’s largest bank by assets, said on Thursday it would offer 500 billion yuan (US$75.4 billion) worth of credit to support the home rental market in Guangzhou.
Upvote Downvote

 
Largest operator of warehousing space in China, Singaporean logistics giant GLP, posts 34pc second quarter profit rise

2017-11-10 scmp
Results come after finalisation of a US$11.6b management-led buyout of the firm by a consortium led by developer China Vanke Co and Goldman Sachs’ former China chairman – Asia’s biggest-ever private equity acquisition by value
Upvote Downvote

 
Four tap into asset-backed securities on rental flats – who’ll be next?

2017-11-08 scmp
Following Mofang and Ziroom’s successful issuance of Asset Backed Securities (ABS), China Young Professional Apartments (CYPA) and Poly Real Estate (Poly China) have now been given the green light to launch quasi-Real Estate Investment Trusts (REITs). Property developers, such as China Vanke, CIFI Holdings (Group), Longfor Properties and Landsea Green Properties, Poly China has entered the business of long-term rental spaces.
Upvote Downvote

 
Chinese banks being tempted into residential leasing market

2017-11-06 scmp
China Construction Bank first of country’s big four to make serious commitment, with others lining up to follow
Upvote Downvote

 
What's in a Chinese Sausage? - Bloomberg Gadfly

2017-11-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
With asset-backed securities sorted for builders, China now needs to develop reit market

2017-10-31 scmp
Reits are popular with investors in developed markets like the US, but legal and regulatory hurdles are preventing the launch of these products in China
Upvote Downvote

 
Sun Hongbin: from outside top 50 to China’s fourth-richest property tycoon in just 12 months

2017-10-30 scmp
A series of aggressive asset purchases over the past year has propelled real estate magnate Sun Hongbin into China’s top five property billionaires, from outside the top 50, 12 months ago.
Upvote Downvote

1
The Real Wealth Of Asia Exposed

2017-10-18 seekingalpha
Capital is an asset that has the potential to create more value. It captures both the physical dimension and its potential to generate surplus value of an asset.
Upvote Downvote

 
Shanghai’s ‘co-living’ operator Harbour Apartments eyes expansion in eight Chinese cities including Hong Kong

2017-10-11 scmp
Harbour’s target is to create 20,000 rentable co-living units in eight Chinese cities including by the end of 2017, to quadruple that number to 80,000 by 2019, and hit the million market with a possible float of Harbour within five years
Upvote Downvote

Related Articles

GNCA: Genocea Biosciences Analysis and Research Report

11h - Asif

Overview Genocea Biosciences is a biopharmaceutical company that discovers and develops novel cancer vaccines. The company use its proprietary discovery platform, ATLAS, to recall a patient’s pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. The company believe that using ATLAS to identify antigens for inclusion in cancer vaccines could lead to more immunogenic and efficacious cancer vaccines. In September 2017, the company announced a strategic shift to immuno-oncology and a focus on the development of neoantigen cancer vaccines. Currently, all of its research programs and product candidates in active development are at the preclinical stage. The company's most advanced program is its preclinical immuno-oncology program, GEN-009, a neoantigen cancer vaccine. The GEN-009 program uses ATLAS to identify patient neoantigens, or newly formed anti...

AMZN: Amazon.com, Inc Analysis and Research Report

11h - Asif

Overview Amazon.com opened its virtual doors on the World Wide Web in July 1995. The company seek to be Earth’s most customer-centric company. Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. In each of its segments, the company serve its primary customer sets, consisting of consumers, sellers, developers, enterprises, and content creators. In addition, the company provide services, such as advertising services and co-branded credit card agreements. Amazon has organized its operations into three segments: North America, International, and Amazon Web Services (“AWS”). These segments reflect the way the Company evaluates its business performance and manages its operations. Additional information on its operating segments and its net sales is contained in Item 8 of Part II, “Financial Statements and Supplementary Data—Note 11—Segment Information.” The compan...

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

CUSIP: 16948J109